Multifunctionality of lipid-core micelles for drug delivery and tumour targeting

Molecular Membrane Biology

Volumn 27, Issue 7, 2010, Pages 232-246

  Sawant, Rupa R ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

cancer targeting; Phospholipid micelles; stimuli sensitive nanocarriers

Indexed keywords

CAMPTOTHECIN; CISPLATIN; CLONAZEPAM; DEQUALINIUM; DEXTRAN B POLY(EPSILON CAPROLACTONE)DIBLOCK COPOLYMER; DOXORUBICIN; EPIRUBICIN; GRISEOFULVIN; HALOPERIDOL; IBUPROFEN; INDOMETACIN; L 685818; MACROGOL; MENADIONE; NANOCARRIER; PACLITAXEL; POLOXAMER; POLY(BETA BENZYL L ASPARTATE)B POLYETHYLENEGLYCOL; POLY(D,L LACTIDE)B METHOXY POLYETHYLENEGLYCOL; POLY(GAMMA BENZYL L GLUTAMATE)B POLYETHYLENEGLYCOL; POLY(L LYSINE)B POLYETHYLENEGLYCOL; POLY(N ISOPROPYLACRYLAMIDE)B POLYETHYLENEGLYCOL; POLY(N VINYL 2 PYRROLIDONE)B POLY(D,L LACTIDE); POLYCAPROLACTONE B METHOXY POLYETHYLENEGLYCOL; POLYCARPROLACTONE B POLYETHYLENEGLYCOL; POLYETHYLENEGLYCOL B POLY(LACTIC CO GLYCOLIC ACID); POLYETHYLENEGLYCOL PHOSPHATIDYLETHANOLAMINE; PORPHYRIN; TACROLIMUS; TESTOSTERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CANCER CHEMOTHERAPY; CHEMICAL STRUCTURE; CRITICAL MICELLE CONCENTRATION; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG PENETRATION; DRUG RETENTION; DRUG STABILITY; DRUG TARGETING; ENDOCYTOSIS; HUMAN; LEWIS CARCINOMA; MICELLE; NONHUMAN; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MICE; MICELLES; NANOPARTICLES; PACLITAXEL; PERMEABILITY; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; SOLUBILITY;

EID: 78049341053     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687688.2010.516276     Document Type: Review

References (126)

1. Alakhov V, Moskaleva E, Batrakova EV, Kabanov AV. 1996. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjug Chem 7:209-216.
2. Alakhov VY, Kabanov AV. 1998. Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Opin Investig Drugs 7:1453-1473.
3. Allen C, Yu Y, Maysinger D, Eisenberg A. 1998. Polycaprolactone-b- poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818. Bioconjug Chem 9:564-572.
4. Ambade AV, Savariar EN, Thayumanavan S. 2005. Dendrimeric micelles for controlled drug release and targeted delivery. Mol Pharm 2:264-272.
5. Arimura H, Ohya Y, Ouchi T. 2005. Formation of core-shell type biodegradable polymeric micelles from amphiphilic poly(aspar-tic acid)-block-polylactide diblock copolymer. Biomacromole-cules 6:720-725.
6. Astriab-Fisher A, Sergueev D, Fisher M, Shaw BR, Juliano RL. 2002.Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions. Pharm Res 19:744-754.
7. Bae Y, Kataoka K. 2009. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copo-lymers. Adv Drug Deliv Rev 61:768-784.
8. Bareford LM, Swaan PW. 2007. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59:748-758.
9. Batrakova EV, Dorodnych TY, Klinskii EY, Kliushnenkova EN, Shemchukova OB, Goncharova ON, Arjakov SA, Alakhov VY, Kabanov AV. 1996. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: In vivo evaluation of anti-cancer activity. Br J Cancer 74:1545-1552.
10. Benahmed A, Ranger M, Leroux JC. 2001. Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,L- lactide). Pharm Res 18: 323-328.
11. Carr BI, Wang Z, Kar S. 2002. K vitamins, PTP antagonism, and cell growth arrest. J Cell Physiol 193:263-274.
12. Chen W-Y, Su C-K, Patrickios CS, Hertler WR, Hatton TA. 1995. Effect of block size and sequence on the micellization of ABC triblock methacrylic acid polyampholytes. Macromolecules 28:8604-8611.
13. Cheon Lee S, Kim C, Chan Kwon I, Chung H, Young Jeong S. 2003.Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. J Control Release 89:437-446.
14. Chung JE, Yokoyama M, Aoyagi T, Sakurai Y, Okano T. 1998. Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermore-sponsive core-shell micellar drug carriers. J Control Release 53:119-130.
15. Chung JE, Yokoyama M, Yamato M, Aoyagi T, Sakurai Y, Okano T. 1999. Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). J Control Release 62:115-127.
16. Conner SD, Schmid SL. 2003. Regulated portals of entry into the cell. Nature 422:37-44.
17. Dabholkar RD, Sawant RM, Mongayt DA, Devarajan PV, Torchilin VP. 2006. Polyethylene glycol-phosphatidylethanola-mine conjugate (PEG-PE)-based mixed micelles: Some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm 315:148-157.
18. Djordjevic J, Barch M, Uhrich KE. 2005. Polymeric micelles based on amphiphilic scorpion-like macromolecules: Novel carriers for water-insoluble drugs. Pharm Res 22:24-32.
19. Dufresne MH, Garrec DL, Sant V, Leroux JC, Ranger M. 2004. Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery. Int J Pharm 277:81-90.
20. Fonge H, Lee H, Reilly RM, Allen C. 2010. Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy. Mol Pharm 7:177-186.
21. Forrest ML, Won CY, Malick AW, Kwon GS. 2006. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. J Control Release 110:370-377.
22. Fretz MM, Koning GA, Mastrobattista E, Jiskoot W, Storm G. 2004.OVCAR-3 cells internalize TAT-peptide modified lipo-somes by endocytosis. Biochim Biophys Acta 1665:48-56.
23. Gabizon AA. 1995. Liposome circulation time and tumor targeting: Implications for cancer chemotherapy. Adv Drug Deliv Rev 16:285-294.
24. Gao H, Yang YW, Fan YG, Ma JB. 2006. Conjugates of poly(DL-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(beta-cyclodextrin)s and their nanoparticles as protein delivery systems. J Control Release 112:301-311.
25. GaoZ, Lukyanov AN, Chakilam AR, Torchilin VP. 2003. PEG-PE/ phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. J Drug Target 11:87-92.
26. Gao Z, Lukyanov AN, Singhal A, Torchilin VP. 2002. Diacyl polymer micelles as nanocarriers for poorly soluble anticancer drugs. Nano Lett 2:979-982.
27. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H. 1994. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71:219-225.
28. Harada A, Kataoka K. 1995. Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block copolymers with poly9ethylene glycol) segments. Macro-molecules 28:5294-5299.
29. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. 1998. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci USA 95:4607-4612.
30. Inoue T, Chen G, Nakamae K, Hoffman AS. 1998. An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. J Control Release 51:221-229.
31. Jeong YI, Cheon JB, Kim SH, Nah JW, Lee YM, Sung YK, Akaike T, Cho CS. 1998. Clonazepam release from core-shell type nanoparticles in vitro. J Control Release, 51:169-178.
32. Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T, Cho CS. 2005.Cellular recognition of paclitaxel-loaded polymeric nano-particles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm 296:151-161.
33. Jiang GB, Quan D, Liao K, Wang H. 2006. Novel polymer micelles prepared from chitosan grafted hydrophobic palmitoyl groups for drug delivery. Mol Pharm 3:152-160.
34. Jones M, Leroux J. 1999. Polymeric micelles-a new generation of colloidal drug carriers. Eur J Pharm Biopharm 48:101-111.
35. Kabanov AV, Chekhonin VP, Alakhov V, Batrakova EV, Lebedev AS, Melik-Nubarov NS, Arzhakov SA, Levashov AV, Morozov GV, Severin ES, et al. 1989. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett 258:343-345.
36. Kang N, Perron ME, Prud'homme RE, Zhang Y, Gaucher G, Leroux JC. 2005. Stereocomplex block copolymer micelles: Core-shell nanostructures with enhanced stability. Nano Lett 5:315-319.
37. Kataoka K, Harada A, Nagasaki Y. 2001. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Deliv Rev 47:113-131.
38. Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kwon GS. 2000. Doxorubicin-loaded poly(ethylene glycol)-poly(beta- benzyl-L-aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance. J Control Release 64:143-153.
39. Katayose S, Kataoka K. 1997. Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconjug Chem 8:702-707.
40. Katayose S, Kataoka K. 1998. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(L-lysine) block copolymer. J Pharm Sci 87:160-163.
41. Kawano K, Watanabe M, Yamamoto T, Yokoyama M, Opanasopit P, Okano T, Maitani Y. 2006. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. J Control Release 112:329-332.
42. Kim D, Gao ZG, Lee ES, Bae YH. 2009. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Mol Pharm 6:1353-1362.
43. Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Wan Kim S, Seo MH. 2001. In vivo evaluation of polymeric micellar pac-litaxel formulation: Toxicity and efficacy. J Control Release 72:191-202.
44. Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, Kim NK, Bang YJ. 2004. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 10:3708-3716.
45. Kwon GS, Naito S, Kataoka K, Yokoyama M, Sakurai Y, Okano T. 1994. Block copolymer micelles as vehicles for hydrophobic drugs. Colloids Surf B Biointerfaces 2:429-434.
46. Kwon GS, Okano T. 1999. Soluble self-assembled block copoly-mers for drug delivery. Pharm Res 16:597-600.
47. Kwon GS, Yokoyama M, Okano T, Sakurai Y, Kataoka K. 1993. Biodistribution of micelle-forming polymer-drug conjugates. Pharm Res 10:970-974.
48. La SB, Okano T, Kataoka K. 1996. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. J Pharm Sci 85:85-90.
49. Lallemand F, Felt-Baeyens O, Besseghir K, Behar-Cohen F, Gurny R. 2003. Cyclosporine A delivery to the eye: A pharmaceutical challenge. Eur J Pharm Biopharm 56:307-318.
50. Lavasanifar A, Samuel J, Kwon GS. 2002. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 54:169-190.
51. Le Garrec D, Gori S, Luo L, Lessard D, Smith DC, Yessine MA, Ranger M, Leroux JC. 2004. Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydropho-bic anticancer drugs: In vitro and in vivo evaluation. J Control Release 99:83-101.
52. Lee ES, Na K, Bae YH. 2003. Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release 91:103-113.
53. Levchenko TS, Rammohan R, Volodina N, Torchilin VP. 2003. Tat peptide-mediated intracellular delivery of liposomes. Methods Enzymol 372:339-349.
54. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. 2000. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18:410-414.
55. Li L, Tan YB. 2008. Preparation and properties of mixed micelles made of Pluronic polymer and PEG-PE. J Colloid Interface Sci 317:326-331.
56. Li M, Chrastina A, Levchenko T, Torchilin VP. 2005. Micelles from poly(ethylene glycol)-phosphatidyl ethanolamine conjugates (PEG-PE) as pharmaceutical nanocarriers for poorly soluble drug camptothecin. J Biomed Nanotechnol 1:190-195.
57. Lin SY, Kawashima Y. 1985. The influence of three poly(oxyethy-lene) poly(oxypropylene) surface-active block copolymers on the solubility behavior of indomethacin. Pharm Acta Helv 60: 339-344.
58. Lin SY, Kawashima Y. 1987. Pluronic surfactants affecting diaz-epam solubility, compatibility, and adsorption from i.v. admixture solutions. J Parenter Sci Technol 41:83-87.
59. Lin WJ, Juang LW, Lin CC. 2003. Stability and release performance of a series of pegylated copolymeric micelles. Pharm Res 20:668-673.
60. Liu J, Lee H, Allen C. 2006. Formulation of drugs in block copolymer micelles: Drug loading and release. Curr Pharm Des 12:4685-4701.
61. Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. 2002. Polyethylene glycol-diacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm Res 19: 1424-1429.
62. Lukyanov AN, Hartner WC, Torchilin VP. 2004. Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits. J Control Release 94:187-193.
63. Lukyanov AN, Torchilin VP. 2004. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 56:1273-1289.
64. Maeda H. 2001. SMANCS and polymer-conjugated macromolec-ular drugs: Advantages in cancer chemotherapy. Adv Drug Deliv Rev 46:169-185.
65. Maeda H, Sawa T, Konno T. 2001. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 74:47-61.
66. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 65:271-284.
67. Martin A, editor. 1993. Physical pharmacy. Philadelphia, USA: Lippincott, Williams and Wilkins.
68. Mathot F, Van Beijsterveldt L, Preat V, Brewster M, Arien A. 2006. Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. J Control Release 111:47-55.
69. Matsumura Y, Yokoyama M, Kataoka K, Okano T, Sakurai Y, Kawaguchi T, Kakizoe T. 1999. Reduction of the side effects of an antitumor agent, KRN5500, by incorporation of the drug into polymeric micelles. Jpn J Cancer Res 90:122-128.
70. Mikhail AS, Allen C. 2009. Block copolymer micelles for delivery of cancer therapy: Transport at the whole body, tissue and cellular levels. J Control Release 138:214-223.
71. Mozafari MR, Pardakhty A, Azarmi S, Jazayeri JA, Nokhodchi A, Omri A. 2009. Role of nanocarrier systems in cancer nanother-apy. J Liposome Res 19:310-321.
72. Mukherjee S, Ghosh RN, Maxfield FR. 1997. Endocytosis. Physiol Rev 77:759-803.
73. Nasongkla N, Shuai X, Ai H, Weinberg BD, Pink J, Boothman DA, Gao J. 2004. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Engl 43: 6323-6327.
74. Nguyen J, Xie X, Neu M, Dumitrascu R, Reul R, Sitterberg J, Bakowsky U, Schermuly R, Fink L, Schmehl T, Gessler T, Seeger W, Kissel T. 2008. Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs. J Gene Med 10:1236-1246.
75. Nishikawa Y, Carr BI, Wang M, Kar S, Finn F, Dowd P, Zheng ZB, Kerns J, Naganathan S. 1995. Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J Biol Chem 270:28304-28310.
76. Nishiyama N, Kataoka K. 2001. Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiam-mineplatinum(II) in the core. J Control Release 74:83-94.
77. Nutter LM, Cheng AL, Hung HL, Hsieh RK, Ngo EO, Liu TW. 1991. Menadione: Spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines. Biochem Pharmacol 41:1283-1292.
78. Park EK, Kim SY, Lee SB, Lee YM. 2005. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J Control Release 109:158-168.
79. Parr MJ, Masin D, Cullis PR, Bally MB. 1997. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: The lack of beneficial effects by coating lipo-somes with poly(ethylene glycol). J Pharmacol Exp Ther 280:1319-1327.
80. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. 2007. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751-760.
81. Pierri E, Avgoustakis K. 2005. Poly(lactide)-poly(ethylene glycol) micelles as a carrier for griseofulvin. J Biomed Mater Res A 75:639-647.
82. Pillion DJ, Amsden JA, Kensil CR, Recchia J. 1996. Structure-function relationship among Quillaja saponins serving as exci-pients for nasal and ocular delivery of insulin. J Pharm Sci 85:518-524.
83. Prompruk K, Govender T, Zhang S, Xiong CD, Stolnik S. 2005. Synthesis of a novel PEG-block-poly(aspartic acid-stat-phenyl-alanine) copolymer shows potential for formation of a micellar drug carrier. Int J Pharm 297:242-253.
84. Rao KS, Reddy MK, Horning JL, Labhasetwar V. 2008. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29:4429-4438.
85. Roby A, Erdogan S, Torchilin VP. 2006. Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro. Eur J Pharm Biopharm 62:235-240.
86. Savic R, Azzam T, Eisenberg A, Maysinger D. 2006. Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: A fluorogenic-based approach. Langmuir 22:3570-3578.
87. Sawant RM, Hurley JP, Salmaso S, Kale A, Tolcheva E, Levchenko TS, Torchilin VP. 2006. 'SMART' drug delivery systems: Double-targeted pH-responsive pharmaceutical nano-carriers. Bioconjug Chem 17:943-949.
88. Sawant RR, Sawant RM, Kale AA, Torchilin VP. 2008a. The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells. J Drug Target 16:596-600.
89. Sawant RR, Sawant RM, Torchilin VP. 2008b. Mixed PEG-PE/ vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: Improved drug solubilization and enhanced in vitro cytotoxicity. Eur J Pharm Biopharm 70: 51-57.
90. Sawant RR, Torchilin VP. 2009. Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. Int J Pharm 374:114-118.
91. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. 1999. In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science 285:1569-1572.
92. Sethuraman VA, Bae YH. 2007. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J Control Release 118:216-224.
93. Shin IG, Kim SY, Lee YM, Cho CS, Sung YK. 1998. Methoxy poly (ethylene glycol)/epsilon-caprolactone amphiphilic block copol-ymeric micelle containing indomethacin. I. Preparation and characterization. J Control Release 51:1-11.
94. Shuai X, Merdan T, Schaper AK, Xi F, Kissel T. 2004. Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjug Chem 15:441-448.
95. Skidan I, Dholakia P, Torchilin V. 2008. Photodynamic therapy of experimental B-16 melanoma in mice with tumor-targeted 5,10,15,20- tetraphenylporphin-loaded PEG-PE micelles. J Drug Target 16:486-493.
96. Slepnev VI, Kuznetsova LE, Gubin AN, Batrakova EV, Alakhov V, Kabanov AV. 1992. Micelles of poly(oxyethylene)-poly(oxypro-pylene) block copolymer (pluronic) as a tool for low-molecular compound delivery into a cell: Phosphorylation of intracellular proteins with micelle incorporated [gamma-32P]ATP. Biochem Int 26:587-595.
97. Soga O, Van Nostrum CF, Fens M, Rijcken CJ, Schiffelers RM, Storm G, Hennink WE. 2005. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J Control Release 103:341-353.
98. Sun H, Guo B, Li X, Cheng R, Meng F, Liu H, Zhong Z. 2010. Shell-sheddable micelles based on dextran-SS-poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicin. Biomacromolecules 11:848-854.
99. Torchilin V. 2009. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm 71: 431-444.
100. Torchilin VP. 2001. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73:137-172.
101. Torchilin VP. 2005a. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. Adv Drug Deliv Rev 57:95-109.
102. Torchilin VP. 2005b. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145-160.
103. Torchilin VP. 2007. Micellar nanocarriers: Pharmaceutical perspectives. Pharm Res 24:1-16.
104. Torchilin VP, Levchenko TS, Lukyanov AN, Khaw BA, Klibanov AL, Rammohan R, Samokhin GP, Whiteman KR. 2001a. p-Nitrophenylcarbonyl-PEG-PE-liposomes: Fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbo-nyl groups. Biochim Biophys Acta 1511:397-411.
105. Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B. 2003. Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA 100:6039-6044.
106. Torchilin VP, Rammohan R, Weissig V, Levchenko TS. 2001b. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA 98: 8786-8791.
107. Uchino H, Matsumura Y, Negishi T, Koizumi F, Hayashi T, Honda T, Nishiyama N, Kataoka K, Naito S, Kakizoe T. 2005. Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats. Br J Cancer 93:678-687.
108. Van Zuylen L, Verweij J, Sparreboom A. 2001. Role of formulation vehicles in taxane pharmacology. Invest New Drugs 19: 125-141.
109. Vaupel P, Kallinowsky F, Okunieff P. 1989. Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors: A review. Cancer Res 49:6449-6465.
110. Vives E, Richard JP, Rispal C, Lebleu B. 2003. TAT peptide internalization: Seeking the mechanism of entry. Curr Protein Pept Sci 4:125-132.
111. Wadia JS, Stan RV, Dowdy SF. 2004. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10:310-315.
112. Wang J, Mongayt D, Torchilin VP. 2005. Polymeric micelles for delivery of poorly soluble drugs: Preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids. J Drug Target 13:73-80.
113. Wang J, Mongayt DA, Lukyanov AN, Levchenko TS, Torchilin VP. 2004. Preparation and in vitro synergistic anti-cancer effect of vitamin K3 and 1,8-diazabicyclo[5,4,0]undec-7-ene in poly(ethylene glycol)-diacyllipid micelles. Int J Pharm 272:129-135.
114. Watanabe M, Kawano K, Yokoyama M, Opanasopit P, Okano T, Maitani Y. 2006. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. Int J Pharm 308:183-189.
115. Weiping S, Changqing Y, Yanjing C, Zhiguo Z, Xiangzheng K. 2006. Self-assembly of an amphiphilic derivative of chitosan and micellar solubilization of puerarin. Colloids Surf B Biointerfaces 48:13-16.
116. Weissig V, Lizano C, Torchilin VP. 1998a. Micellar delivery system for dequalinium-a lipophilic cationic drug with anticarcinoma activity. J Liposome Res 8:391-400.
117. Weissig V, Whiteman KR, Torchilin VP. 1998b. Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm Res 15: 1552-1556.
118. Yokoyama M, Fukushima S, Uehara R, Okamoto K, Kataoka K, Sakurai Y, Okano T. 1998a. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Release 50:79-92.
119. Yokoyama M, Kwon GS, Okano T, Sakurai Y, Seto T, Kataoka K. 1992. Preparation of micelle-forming polymer-drug conjugates. Bioconjug Chem 3:295-301.
120. Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Inoue S. 1990. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adria-mycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 50:1693-1700.
121. Yokoyama M, Satoh A, Sakurai Y, Okano T, Matsumura Y, Kakizoe T, Kataoka K. 1998b. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Control Release 55:219-229.
122. Yu BG, Okano T, Kataoka K, Kwon G. 1998. Polymeric micelles for drug delivery: Solubilization and haemolytic activity of amphotericin B. J Control Release 53:131-136.
123. Zeng F, Lee H, Allen C. 2006. Epidermal growth factor-conjugated poly(ethylene glycol)-block-poly(delta-valerolactone) copoly-mer micelles for targeted delivery of chemotherapeutics. Bio-conjug Chem 17:399-409.
124. Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W. 2010. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Control Release 143:136-142.
125. Zhao M, Kircher MF, Josephson L, Weissleder R. 2002. Differential conjugation of tat peptide to superparamagnetic nano-particles and its effect on cellular uptake. Bioconjug Chem 13:840-844.
126. Zorko M, Langel U. 2005. Cell-penetrating peptides: Mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev 57: 529-545.